CD371-YSNVZ-IL18 CAR T cells
/ Memorial Sloan-Kettering Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 30, 2023
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=6 | Recruiting | Sponsor: Memorial Sloan Kettering Cancer Center
CAR T-Cell Therapy • New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD37 • FLT3 • IDH1 • IDH2 • IL18
1 to 1
Of
1
Go to page
1